Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
645 | 3212 | 36.8 | 80% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
10 | 3 | IMMUNOLOGY//JOURNAL OF IMMUNOLOGY//IMMUNOL | 134299 |
854 | 2 | CD40//BAFF//CD40 LIGAND | 11643 |
645 | 1 | TUMOR NECROSIS FACTOR//TNF RECEPTOR//MORRIS HEPATOMA 5123 | 3212 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | TUMOR NECROSIS FACTOR | authKW | 147698 | 8% | 6% | 265 |
2 | TNF RECEPTOR | authKW | 96712 | 2% | 18% | 57 |
3 | MORRIS HEPATOMA 5123 | authKW | 85543 | 0% | 100% | 9 |
4 | TUMOR NECROSIS FACTOR RECEPTOR | authKW | 68437 | 1% | 18% | 40 |
5 | LYMPHOKINE AND CYTOKINE RESEARCH | journal | 55308 | 1% | 16% | 37 |
6 | SOLUBLE TNF RECEPTORS | authKW | 43428 | 0% | 29% | 16 |
7 | TNF | authKW | 42870 | 3% | 4% | 105 |
8 | LYMPHOTOXIN | authKW | 42022 | 1% | 15% | 29 |
9 | TNF CYTOTOXICITY | authKW | 38019 | 0% | 100% | 4 |
10 | LYMPHOKINE RESEARCH | journal | 37828 | 1% | 12% | 34 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Immunology | 16726 | 35% | 0% | 1128 |
2 | Oncology | 4460 | 21% | 0% | 666 |
3 | Medicine, Research & Experimental | 1995 | 10% | 0% | 331 |
4 | Biochemistry & Molecular Biology | 1899 | 24% | 0% | 757 |
5 | Cell Biology | 1668 | 13% | 0% | 430 |
6 | Hematology | 971 | 6% | 0% | 195 |
7 | Pathology | 264 | 3% | 0% | 105 |
8 | Biophysics | 152 | 4% | 0% | 117 |
9 | Critical Care Medicine | 108 | 1% | 0% | 48 |
10 | Biochemical Research Methods | 55 | 2% | 0% | 77 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | TEACHING WARD INTERNAL MED | 21384 | 0% | 75% | 3 |
2 | UNIT MOL PATHOPHYSIOL EXPT THER Y | 19006 | 0% | 50% | 4 |
3 | AID 1 | 12672 | 0% | 67% | 2 |
4 | GYNECOL SEPT OBSTET | 10689 | 0% | 38% | 3 |
5 | AFFILIATED HOSP 2 UROL | 9505 | 0% | 100% | 1 |
6 | AN BELOZERSKII PHYSIOCHEM BIOL | 9505 | 0% | 100% | 1 |
7 | ARMY MOL BIOL ANAL | 9505 | 0% | 100% | 1 |
8 | BEREICH PHARMAZEUT CHEM BIOANALYT | 9505 | 0% | 100% | 1 |
9 | BEUTENBERGSTR 11 | 9505 | 0% | 100% | 1 |
10 | BIOCHEM BIOPHARM MOL BIOL | 9505 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | LYMPHOKINE AND CYTOKINE RESEARCH | 55308 | 1% | 16% | 37 |
2 | LYMPHOKINE RESEARCH | 37828 | 1% | 12% | 34 |
3 | JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS | 25227 | 1% | 7% | 36 |
4 | JOURNAL OF INFLAMMATION | 17305 | 0% | 15% | 12 |
5 | EUROPEAN CYTOKINE NETWORK | 8644 | 1% | 3% | 30 |
6 | CYTOKINE | 7655 | 2% | 1% | 60 |
7 | JOURNAL OF IMMUNOLOGY | 6377 | 6% | 0% | 193 |
8 | BIOTHERAPY | 5439 | 0% | 4% | 13 |
9 | JAPANESE JOURNAL OF CANCER RESEARCH | 4226 | 1% | 1% | 40 |
10 | JOURNAL OF EXPERIMENTAL MEDICINE | 3378 | 2% | 1% | 67 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TUMOR NECROSIS FACTOR | 147698 | 8% | 6% | 265 | Search TUMOR+NECROSIS+FACTOR | Search TUMOR+NECROSIS+FACTOR |
2 | TNF RECEPTOR | 96712 | 2% | 18% | 57 | Search TNF+RECEPTOR | Search TNF+RECEPTOR |
3 | MORRIS HEPATOMA 5123 | 85543 | 0% | 100% | 9 | Search MORRIS+HEPATOMA+5123 | Search MORRIS+HEPATOMA+5123 |
4 | TUMOR NECROSIS FACTOR RECEPTOR | 68437 | 1% | 18% | 40 | Search TUMOR+NECROSIS+FACTOR+RECEPTOR | Search TUMOR+NECROSIS+FACTOR+RECEPTOR |
5 | SOLUBLE TNF RECEPTORS | 43428 | 0% | 29% | 16 | Search SOLUBLE+TNF+RECEPTORS | Search SOLUBLE+TNF+RECEPTORS |
6 | TNF | 42870 | 3% | 4% | 105 | Search TNF | Search TNF |
7 | LYMPHOTOXIN | 42022 | 1% | 15% | 29 | Search LYMPHOTOXIN | Search LYMPHOTOXIN |
8 | TNF CYTOTOXICITY | 38019 | 0% | 100% | 4 | Search TNF+CYTOTOXICITY | Search TNF+CYTOTOXICITY |
9 | MUTEINS | 34212 | 0% | 60% | 6 | Search MUTEINS | Search MUTEINS |
10 | HTNF RECEPTORS | 28514 | 0% | 100% | 3 | Search HTNF+RECEPTORS | Search HTNF+RECEPTORS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SIDHU, RS , BOLLON, AP , (1993) TUMOR-NECROSIS-FACTOR ACTIVITIES AND CANCER-THERAPY - A PERSPECTIVE.PHARMACOLOGY & THERAPEUTICS. VOL. 57. ISSUE 1. P. 79-128 | 284 | 56% | 92 |
2 | BEUTLER, B , CERAMI, A , (1989) THE BIOLOGY OF CACHECTIN/TNF - A PRIMARY MEDIATOR OF THE HOST RESPONSE.ANNUAL REVIEW OF IMMUNOLOGY. VOL. 7. ISSUE . P. 625-655 | 102 | 56% | 1586 |
3 | VANOSTADE, X , TAVERNIER, J , FIERS, W , (1994) STRUCTURE-ACTIVITY STUDIES OF HUMAN TUMOR NECROSIS FACTORS.PROTEIN ENGINEERING. VOL. 7. ISSUE 1. P. 5-22 | 129 | 84% | 71 |
4 | FIERS, W , (1991) TUMOR-NECROSIS-FACTOR - CHARACTERIZATION AT THE MOLECULAR, CELLULAR AND INVIVO LEVEL.FEBS LETTERS. VOL. 285. ISSUE 2. P. 199-212 | 88 | 73% | 636 |
5 | JAATTELA, M , (1991) BIOLOGIC ACTIVITIES AND MECHANISMS OF ACTION OF TUMOR-NECROSIS-FACTOR-ALPHA CACHECTIN.LABORATORY INVESTIGATION. VOL. 64. ISSUE 6. P. 724-742 | 138 | 53% | 278 |
6 | AGGARWAL, BB , NATARAJAN, K , (1996) TUMOR NECROSIS FACTORS: DEVELOPMENTS DURING THE LAST DECADE.EUROPEAN CYTOKINE NETWORK. VOL. 7. ISSUE 2. P. 93-124 | 127 | 41% | 451 |
7 | BEUTLER, B , CERAMI, A , (1988) TUMOR NECROSIS, CACHEXIA, SHOCK, AND INFLAMMATION - A COMMON MEDIATOR.ANNUAL REVIEW OF BIOCHEMISTRY. VOL. 57. ISSUE . P. 505-518 | 69 | 78% | 845 |
8 | ROBERTS, NJ , ZHOU, SB , DIAZ, LA , HOLDHOFF, M , (2011) SYSTEMIC USE OF TUMOR NECROSIS FACTOR ALPHA AS AN ANTICANCER AGENT.ONCOTARGET. VOL. 2. ISSUE 10. P. 739-751 | 58 | 68% | 42 |
9 | MACEWAN, DJ , (2002) TNF RECEPTOR SUBTYPE SIGNALLING: DIFFERENCES AND CELLULAR CONSEQUENCES.CELLULAR SIGNALLING. VOL. 14. ISSUE 6. P. 477 -492 | 122 | 31% | 380 |
10 | SHERRY, B , CERAMI, A , (1988) CACHECTIN TUMOR NECROSIS FACTOR EXERTS ENDOCRINE, PARACRINE, AND AUTOCRINE CONTROL OF INFLAMMATORY RESPONSES.JOURNAL OF CELL BIOLOGY. VOL. 107. ISSUE 4. P. 1269-1277 | 82 | 71% | 448 |
Classes with closest relation at Level 1 |